The NSCBCA's Playbook Against Prostate Cancer
Opposition Analysis
In 2024, there will be approximately 300,000 new diagnoses and 35,000 prostate cancer-related deaths.
2nd
leading cancer-related cause of death in men
1 in 8
men will be diagnosed during their lifetime*
1 in 44
men will die of prostate cancer
3.3 million
men diagnosed in the U.S. have beat the odds and live on
97.1%
is the relative 5-year survival rate with early detection
*That means of NHSBCA’s xxx [insert total #] members, xxx [insert ⅛ of total #] of you may face the same opponent.
Fresh Off A Win
imaware, Mayo Clinic and ManUp teamed up at the 2024 NCAA Final Four events to raise awareness and put prostate-specific antigen (PSA) levels to the test — with game-changing results:
119
coaches and attendees completed tests
7
%
received elevated results and follow-up care
21
NCAA event-goers are now facing their risk head-on
Home Court Advantage
One finger prick and a few drops of blood collected in the comfort of your home are all the imaware Prostate Cancer Screening Test requires. Our lab will analyze your PSA data and flag elevated levels in your private patient portal. Mayo Clinic’s team will reach out directly to coaches with abnormal results to help you take action.
DON'T drop the ball on testing
Prostate Cancer Screening Test
Price
$89
Analysis
All of imaware tests are performed by CLIA-certified, CAP-accredited labs, the gold standard in lab testing quality regulation
Collection
Quick and easy finger prick sample collection method with just a few drops of blood from the fingertip
Biomarker measured
PSA (Prostate-Specific Antigen)
**Mayo providers will reach out to you if there are any areas of concern. Please keep in mind that due to high volumes, high-risk patients will be prioritized, which may cause delays in consultation scheduling. Thank you for your patience.
